Bioventus hits lowest after 2022 sales forecast cut

Bioventus

08/11/2022 15:36

** Shares of medical device maker Bioventus Inc  BVS.O 
plunge 38.1% to $4.37 in early trade - hitting their all-time
low
    ** Co lowers FY 2022 sales forecast to $527 mln-$532 mln
from an earlier range of $547.5 mln-$562.5 mln  urn:newsml:reuters.com:*:nGNX3mwWmr
    ** BVS also has a higher debt obligation after Q3 than at
the end of December last year
    ** Co says its guidance reflects its current expectations
regarding the impact of COVID-19 on its business
    ** Q3 adj. profit of $0.08/shr misses market expectation of
$0.12/shr - Refinitiv Data
    ** Including session losses, stock down 70.3% YTD
 (Reporting by Sourasis Bose in Bengaluru)
 ((Sourasis.bose@thomsonreuters.com))